May 15, 2006
HandyLab, Inc., a developer of novel clinical diagnostic testing products, announced the completion of a $5.6 million private equity financing. Combined with a $6 million round completed in December of last year, HandyLab has obtained $11.6 million in private equity funding over the last five months.
Read more...
November 16, 2005
DuPont Qualicon and HandyLab, Inc today announced that they have signed an agreement to jointly develop new products for food testing using microfluidics to shorten sample preparation time.
Read more...
HandyLab, Inc., a developer of novel clinical diagnostic testing products, announced the completion of a $5.6 million private equity financing. Combined with a $6 million round completed in December of last year, HandyLab has obtained $11.6 million in private equity funding over the last five months.
Read more...
November 16, 2005
DuPont Qualicon and HandyLab, Inc today announced that they have signed an agreement to jointly develop new products for food testing using microfluidics to shorten sample preparation time.
Read more...
| Technology HandyLab’s proprietary and patented microfluidic technology enables cartridge-based adaptation of a bench-scale biochemical assay. Multi-step sample and reagent handling processes are seamlessly integrated into devices capable of completing the entire assay without any manual intervention. |
|
| HandyLab's Unitized Reagent Strip The unitized reagent strip accepts up to 500 microliters of clinical sample in lysis reagent, which is then mixed with proprietary reagents and incubated. The sample preparation process captures the nucleic acid. The targeted nucleic acid is washed and concentrated into 10 microliters. The concentrated nucleic acid is mixed with prepared probes and primes. This final mix is automatically pipetted into a precision microfluidic chamber. |
 |
| Once sealed, the final mixture is amplified and detected real time. When testing is completed, the cartridge is disposed as normal biohazard waste. | |
| Microthermal Circuitry The design of the microfluidic components allow simple control of on-cartridge processes using the proprietary Microthermal Circuit. Housed in the analyzer, this interface device enables automation of the entire sample, amplification, and detection process, providing results from a clinical prep sample in about an hour. |
 |
|
|
